Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Pinder, Roger M.
1979.
Annual Reports in Medicinal Chemistry Volume 14.
Vol. 14,
Issue. ,
p.
1.
Souto, Mario
Francès, Henriette
Lecrubier, Yves
Puech, Alain J.
and
Simon, Pierre
1979.
Antagonism by d,1-propranolol of imipramine effects in mice.
European Journal of Pharmacology,
Vol. 60,
Issue. 1,
p.
105.
Villeneuve, A.
1979.
Neuropsychopharmacology.
p.
187.
Lecrubier, Y.
Puech, A. J.
Jouvent, R.
Simon, P.
and
Widlocher, D.
1980.
A Beta Adrenergic Stimulant (Salbutamol) versus Clomipramine in Depression: A Controlled Study.
British Journal of Psychiatry,
Vol. 136,
Issue. 4,
p.
354.
Wirz-Justice, Anna
Arendt, Josephine
and
Marston, Anne
1980.
Antidepressant drugs elevate rat pineal and plasma melatonin.
Experientia,
Vol. 36,
Issue. 4,
p.
442.
Hall, Håkan
Sällemark, Maria
and
Ross, Svante B.
1980.
Clenbuterol, a Central β‐Adrenoceptor Agonist.
Acta Pharmacologica et Toxicologica,
Vol. 47,
Issue. 2,
p.
159.
Hallberg, Hel�ne
Almgren, O.
and
Svensson, T. H.
1980.
Reduced brain monoamine synthesis by systemic treatment with terbutaline, a ?2-receptor agonist.
Journal of Neural Transmission,
Vol. 48,
Issue. 3,
p.
167.
van Praag, H.M.
1980.
Central monoamine metabolism in depressions. II. Catecholamines and related compounds.
Comprehensive Psychiatry,
Vol. 21,
Issue. 1,
p.
44.
Hallberg, Heléne
Almgren, Olle
and
Svensson, Torgny H.
1980.
Centralnervösa effekter av beta-2-receptoragonisten salbutamol — ett potentiellt antidepressivt läkemedel?.
Nordisk Psykiatrisk Tidsskrift,
Vol. 34,
Issue. 6,
p.
561.
Belmaker, R.H.
Lerer, B.
and
Ebstein, R.P.
1981.
Recent Advances in Neuropsycho-Pharmacology.
p.
17.
Lerer, B.
Ebstein, R. P.
and
Belmaker, R. H.
1981.
Subsensitivity of human ?-adrenergic adenylate cyclase after salbutamol treatment of depression.
Psychopharmacology,
Vol. 75,
Issue. 2,
p.
169.
Hallberg, Hel�ne
Almgren, Olle
and
Svensson, Torgny H.
1981.
Increased brain serotonergic and noradrenergic activity after repeated systemic administration of the beta-2 adrenoceptor agonist salbutamol, a putative antidepressant drug.
Psychopharmacology,
Vol. 73,
Issue. 3,
p.
201.
Svensson, T. H.
Dahlöf, C.
Engberg, G.
and
Hallberg, H.
1981.
Central pre‐ and postsynaptic monoamine receptors in antidepressant therapy.
Acta Psychiatrica Scandinavica,
Vol. 63,
Issue. s290,
p.
67.
Hollister, Leo E.
1981.
‘Second generation’ antidepressant drugs.
Psychosomatics,
Vol. 22,
Issue. 10,
p.
872.
Prichard, B. N. C.
Owens, C. W. I.
and
Tuckman, J.
1981.
Adrenergic Activators and Inhibitors.
Vol. 54 / 2,
Issue. ,
p.
559.
PRATT, HELENOR F.
1982.
Abuse of salbutamol inhalers in young people.
Clinical & Experimental Allergy,
Vol. 12,
Issue. 2,
p.
203.
1982.
Propranolol and depression.
American Journal of Psychiatry,
Vol. 139,
Issue. 1,
p.
92.
Hallberg, Hel�ne
Almgren, Olle
and
Svensson, Torgny H.
1982.
Reduced brain serotonergic activity after repeated treatment with ?-adrenoceptor antagonists.
Psychopharmacology,
Vol. 76,
Issue. 2,
p.
114.
Lerer, Bernard
and
Sitaram, Natraj
1983.
Clinical strategies for evaluating ect mechanisms — pharmacological, biochemical and psychophysiological approaches.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 7,
Issue. 2-3,
p.
309.
Vardi, Y.
Regev, I.
Rosenbaum, M.
and
Flechter, S.
1983.
The behavioral effect of salbutamol (a beta-adrenergic receptor stimulant) on reserpine- and propranolol-treated rats.
Journal of Neurology,
Vol. 230,
Issue. 1,
p.
43.